Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Amit

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|January 29, 2010
Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?Irit Chermesh, Tania Mashiach, Amnon Amit, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 15, 2025
Timing matters: Surgery-to-chemotherapy interval and outcomes in ovarian cancerYoav Siegler, Avia Omer, Yasmin Yousef, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 17, 2021
The impact of radiation therapy on vaginal biomechanical propertiesEmad Matanes, Revital Linder, Roy Lauterbach, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|June 18, 2014
Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspectiveOrit Kaidar-Person, Roxolyana Abdah-Bortnyak, Amnon Amit, et al.
Anti-Cancer Drugs|November 23, 2013
Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer: a retrospective analysisRam Eitan, Ami Fishman, Michai Meirovitz, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2025
Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomesAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 20, 2023
Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Gynecologic Oncology Reports|April 26, 2022
Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group StudyYoav Brezinov, Tamar Katzir, Ofer Gemer, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|January 29, 2010
Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?Irit Chermesh, Tania Mashiach, Amnon Amit, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 15, 2025
Timing matters: Surgery-to-chemotherapy interval and outcomes in ovarian cancerYoav Siegler, Avia Omer, Yasmin Yousef, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 17, 2021
The impact of radiation therapy on vaginal biomechanical propertiesEmad Matanes, Revital Linder, Roy Lauterbach, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|June 18, 2014
Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspectiveOrit Kaidar-Person, Roxolyana Abdah-Bortnyak, Amnon Amit, et al.
Anti-Cancer Drugs|November 23, 2013
Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer: a retrospective analysisRam Eitan, Ami Fishman, Michai Meirovitz, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2025
Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomesAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 20, 2023
Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Gynecologic Oncology Reports|April 26, 2022
Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group StudyYoav Brezinov, Tamar Katzir, Ofer Gemer, et al.
Pageof 7